Pharmaceutical Technology Europe, Sep 1, 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology Europe, Sep 1, 2009
Formulation
The combination drugs debate: Incompatibility problems can be overcome
By Rajesh Dubey , Avvaru Seshasayana , Satti Phanikumar Reddy , Suryakumar Jayanthi
Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.
The combination drugs debate: unstable and unpatentable
By Malcolm Ross
Combination products have been researched and administered for many years, some successfully and others not.
Is another ODT excipient necessary?
By H. Leonhard Ohrem , Roberto Ognibene
Parteck ODT is a newly introduced ready-to-use excipient for fast melt tablets.
The influence of superdisintegrant choice on the rate of drug dissolution
By Jagdish Balasubramaniam , Tim Bee
The addition of superdisintegrants to oral solid dosage forms can improve disintegration and, in turn, drug dissolution.
Regulatory
Embryonic stem cells: the moral dilemma of patentability and funding
By Beatriz San Martin
Human embryonic stem cells are of immense interest to researchers because of their ability to potentially develop into any kind of tissue.
Validation
The benefits of risk-based analyses during system validation
By Peter Woods , David Beale
When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
Special Report
Belgium: Will its enviable geographic position continue to ensure success in pharma?
By Miyese Ozcan , Sam Joll , Mark Storry
Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.
Business
What to consider when expanding businesses into North America
By William C. Cairns , Gail Steckler
Increase your chances of success in the biggest market in the world.
Ask the Expert
Successful packaging of aseptically prefilled products
By Paul Nelles
Why correctly calibrating a drug with its packaging is the key to success.
Outsourcing Review
Expansion plan
By Jim Miller
In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.
News
News
A round up of news from across the globe.
Editor's Comment
Strength in numbers
By Fedra Pavlou
Merger, union, alliance, partnership, collaboration: five words that ultimately suggest the strengthening of something.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here